Fig. 3From: Identification of characteristic metabolic panels for different stages of prostate cancer by 1H NMR-based metabolomics analysisROC curve analysis of the selected metabolites for differentiating PCaB from BPH. The assessment of the diagnostic performance of A leucine; B isoleucine; C valine; D acetoacetate; E pyruvate; F phenylalanine; G histidine; H formate; I a combination of eight metabolites; J a merger of eight metabolites with age and BMIBack to article page